These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 38360072
1. Intestinal metabolite UroB alleviates cerebral ischemia/reperfusion injury by promoting competition between TRIM65 and TXNIP for binding to NLRP3 inflammasome in response to neuroinflammation. Luo J, Luo Y, Chen J, Gao Y, Tan J, Yang Y, Yang C, Jiang N, Luo Y. Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167056. PubMed ID: 38360072 [Abstract] [Full Text] [Related]
2. Nrf2 inhibits NLRP3 inflammasome activation through regulating Trx1/TXNIP complex in cerebral ischemia reperfusion injury. Hou Y, Wang Y, He Q, Li L, Xie H, Zhao Y, Zhao J. Behav Brain Res; 2018 Jan 15; 336():32-39. PubMed ID: 28851669 [Abstract] [Full Text] [Related]
3. Salvianolic Acids for Injection alleviates cerebral ischemia/reperfusion injury by switching M1/M2 phenotypes and inhibiting NLRP3 inflammasome/pyroptosis axis in microglia in vivo and in vitro. Ma DC, Zhang NN, Zhang YN, Chen HS. J Ethnopharmacol; 2021 Apr 24; 270():113776. PubMed ID: 33421597 [Abstract] [Full Text] [Related]
4. Umbelliferone ameliorates cerebral ischemia-reperfusion injury via upregulating the PPAR gamma expression and suppressing TXNIP/NLRP3 inflammasome. Wang X, Li R, Wang X, Fu Q, Ma S. Neurosci Lett; 2015 Jul 23; 600():182-7. PubMed ID: 26071904 [Abstract] [Full Text] [Related]
5. Corrigendum to "Intestinal metabolite UroB alleviates cerebral ischemia/reperfusion injury by promoting competition between TRIM65 and TXNIP for binding to NLRP3 inflammasome in response to neuroinflammation" [BBA - Molecular Basis of Disease 1870 (2024) 167056]. Luo J, Luo Y, Chen J, Gao Y, Tan J, Yang Y, Yang C, Jiang N, Luo Y. Biochim Biophys Acta Mol Basis Dis; 2024 Oct 23; 1870(7):167285. PubMed ID: 38944594 [No Abstract] [Full Text] [Related]
8. Electroacupuncture attenuated cerebral ischemic injury and neuroinflammation through α7nAChR-mediated inhibition of NLRP3 inflammasome in stroke rats. Jiang T, Wu M, Zhang Z, Yan C, Ma Z, He S, Yuan W, Pu K, Wang Q. Mol Med; 2019 May 22; 25(1):22. PubMed ID: 31117961 [Abstract] [Full Text] [Related]
10. Sulforaphane improves outcomes and slows cerebral ischemic/reperfusion injury via inhibition of NLRP3 inflammasome activation in rats. Yu C, He Q, Zheng J, Li LY, Hou YH, Song FZ. Int Immunopharmacol; 2017 Apr 22; 45():74-78. PubMed ID: 28189971 [Abstract] [Full Text] [Related]
12. Qingkailing injection ameliorates cerebral ischemia-reperfusion injury and modulates the AMPK/NLRP3 Inflammasome Signalling pathway. Ma C, Wang X, Xu T, Yu X, Zhang S, Liu S, Gao Y, Fan S, Li C, Zhai C, Cheng F, Wang Q. BMC Complement Altern Med; 2019 Nov 20; 19(1):320. PubMed ID: 31747940 [Abstract] [Full Text] [Related]
13. Lipocalin-2-mediated astrocyte pyroptosis promotes neuroinflammatory injury via NLRP3 inflammasome activation in cerebral ischemia/reperfusion injury. Li J, Xu P, Hong Y, Xie Y, Peng M, Sun R, Guo H, Zhang X, Zhu W, Wang J, Liu X. J Neuroinflammation; 2023 Jun 23; 20(1):148. PubMed ID: 37353794 [Abstract] [Full Text] [Related]
14. 6-Gingerol protects against cerebral ischemia/reperfusion injury by inhibiting NLRP3 inflammasome and apoptosis via TRPV1 / FAF1 complex dissociation-mediated autophagy. Luo J, Chen J, Yang C, Tan J, Zhao J, Jiang N, Zhao Y. Int Immunopharmacol; 2021 Nov 23; 100():108146. PubMed ID: 34537481 [Abstract] [Full Text] [Related]
15. PHLDA1 Blockade Alleviates Cerebral Ischemia/Reperfusion Injury by Affecting Microglial M1/M2 Polarization and NLRP3 Inflammasome Activation. Zhao H, Liu Y, Chen N, Yu H, Liu S, Qian M, Zhang Z. Neuroscience; 2022 Apr 01; 487():66-77. PubMed ID: 35093445 [Abstract] [Full Text] [Related]
16. Forsythoside B alleviates cerebral ischemia-reperfusion injury via inhibiting NLRP3 inflammasome mediated by SIRT1 activation. Li Q, Zhang C, Sun X, Wang M, Zhang Z, Chen R, Sun X. PLoS One; 2024 Apr 01; 19(6):e0305541. PubMed ID: 38885233 [Abstract] [Full Text] [Related]
17. Protective Effects of Remimazolam on Cerebral Ischemia/Reperfusion Injury in Rats by Inhibiting of NLRP3 Inflammasome-Dependent Pyroptosis. Shi M, Chen J, Liu T, Dai W, Zhou Z, Chen L, Xie Y. Drug Des Devel Ther; 2022 Apr 01; 16():413-423. PubMed ID: 35210755 [Abstract] [Full Text] [Related]
18. Baicalin Inhibits NLRP3 Inflammasome Activity Via the AMPK Signaling Pathway to Alleviate Cerebral Ischemia-Reperfusion Injury. Zheng WX, He WQ, Zhang QR, Jia JX, Zhao S, Wu FJ, Cao XL. Inflammation; 2021 Oct 01; 44(5):2091-2105. PubMed ID: 34080089 [Abstract] [Full Text] [Related]
19. Qingda granule alleviates cerebral ischemia/reperfusion injury by inhibiting TLR4/NF-κB/NLRP3 signaling in microglia. Cai Q, Zhao C, Xu Y, Lin H, Jia B, Huang B, Lin S, Chen D, Jia P, Wang M, Lin W, Zhang L, Chu J, Peng J. J Ethnopharmacol; 2024 Apr 24; 324():117712. PubMed ID: 38184025 [Abstract] [Full Text] [Related]
20. Neuroprotective Effects of Vinpocetine Against Ischemia-Reperfusion Injury Via Inhibiting NLRP3 Inflammasome Signaling Pathway. Hou B, Li D, Wang D, Jiang C, Wang G, Wang D, Yan G, Guo X, Zhao L, Wan Z, Fan C, Cao W, Ren H. Neuroscience; 2023 Aug 21; 526():74-84. PubMed ID: 37290685 [Abstract] [Full Text] [Related] Page: [Next] [New Search]